Evaluation of the Risk of Cognitive Deficit After Surgery of Epilepsy by Dynamic Spectral Imaging (ISD) of the Cognitive Functions in Patients Explored in StereoElectroEncephaloGraphy (SEEG) (ISD SEEG)

January 25, 2024 updated by: Hospices Civils de Lyon

Epilepsy affects between 0.5 and 0.7% of the European population. Despite the availability of numerous drug treatments, one third of patients still have seizures, which are associated with significant cognitive and social complications and excess mortality. In these patients, surgical treatment to remove the epileptogenic zone (EZ), the region of the brain responsible for seizures, is the only approach that can allow control of the disease. However, before investigating this surgery, investigations have to answer two questions: (i) what is the location and extension of the EZ and (ii) what functional risks, both motor and cognitive, would represent the resection of this Cortical region? As it is a functional surgery, it is in fact inconceivable that the surgery will result in an over-handicap. For these reasons, all candidates for surgery benefit from a complete assessment including imaging examinations, a neuropsychological assessment and a long-term video-EEG recording to record seizures. Nevertheless, in some patients, this assessment does not give us a formal answer. In these subjects, it is then necessary to carry out a second step, consisting of an invasive exploration by implantation of intracerebral electrodes during a stereoencephalography (SEEG). Due to its temporal and spatial resolution, the SEEG allows, besides the precise determination of the EZ, to carry out a functional mapping of the cortical regions likely to be included in cortectomy. Conventionally, this mapping is carried out on the basis of the cortical electrical stimulations applied to the implanted electrodes. If this approach is very robust for exploring primary functions such as motor skills or language, it cannot be used to evaluate more complex cognitive tasks such as face recognition or attention Effective cognitive treatment on a daily basis. This has led to the development in recent years, in Lyon and Grenoble, of a complementary approach to cerebral stimulation: dynamic spectral imaging (ISD). Numerous experimental paradigms have demonstrated that the realization of a cognitive task associates with the generation within the cortical regions involved in its treatment of a particular cortical activity. This activity is characterized by oscillations of the cortical rhythm in high frequencies (> 30 Hz), called gamma activities. The ISD thus consists in mapping this gamma activity during various cognitive tasks, thus making it possible to study more widely the complexity of the cognitive functions. Correlations between gamma activity and cognitive tasks have so far been exclusively performed in the non-epileptic cortex explored at the periphery of the EA during SEEG. Nevertheless, the cortical oscillatory pattern study associated with a specific cognitive task within the EZ could better anticipate complex cognitive deficits that could be generated by the resection of a cortical region.

The main objective of this project is to establish the predictive character of the gamma cortical oscillatory pattern associated with a specific cognitive task on the risk of occurrence of a cognitive disorder after surgery of epilepsy.

Study Overview

Status

Recruiting

Conditions

Study Type

Interventional

Enrollment (Estimated)

50

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

  • Name: Anne-Laure CHARLOIS

Study Locations

      • Bron, France, 69500
        • Recruiting
        • Hospices Civils de Lyon
        • Contact:
        • Contact:
          • Anne-Laure CHARLOIS
        • Principal Investigator:
          • Sylvain RHEIMS, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Description

Inclusion Criteria:

  • patient adult (18-65 y/o) without legal protection measures
  • Patient with a drug-resistant focal epilepsy
  • Patient with a SEEG exploration as part of pre-surgical assessment of epilepsy
  • patient with a consent form signed
  • Intellectual capacities compatible with cognitive tasks and the signing of informed consent
  • Affiliation to the social security

Exclusion Criteria:

  • Pregnant women: this is already a contraindication to the realization of a SEEG study
  • Subjects under 18 years of age or over 65 years of age
  • Patient not suffering from EFPR, or not scheduled for SEEG
  • Intellectual capacities incompatible with the cognitive tasks and / or the signature of a consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Diagnostic
  • Allocation: N/A
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Dynamic Spectral Imaging (ISD)
Evaluation of cognitive functions by ISD
cerebral stimulation: dynamic spectral imaging (ISD)

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
predictive character of the cortical gamma oscillatory pattern associated with a specific cognitive task on the risk of occurrence of a cognitive disorder after epilepsy surgery
Time Frame: 12 months post-surgery compare to preoperative assessment (SEEG)
Relation between the presence in the epileptogenic zone of a gamma activation in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a postoperative neuropsychological deficit (Wilcoxon test)
12 months post-surgery compare to preoperative assessment (SEEG)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
database on the dynamics of large cerebral networks underlying the main cognitive functions
Time Frame: pre-surgical assessment (SEEG)
Comparison of mapping of pre-surgical gamma activity with preoperative neu-ropsychological evaluation
pre-surgical assessment (SEEG)
spatio-temporal organization of these networks with that predicted by fMRI
Time Frame: preoperative assessment (SEEG, fMRI and cortical stimulations)
Pre-surgical comparison of the performances for the functional cartography of gamma activity performed during SEEG, fMRI and cortical stimulation at preoperative assessment.
preoperative assessment (SEEG, fMRI and cortical stimulations)
effect of intracerebral electrical stimulations
Time Frame: preoperative assessment (SEEG, fMRI and cortical stimulations)
Pre-surgical comparison of the performances for the functional cartography of gamma activity performed during SEEG, fMRI and cortical stimulation at preoperative assessment.
preoperative assessment (SEEG, fMRI and cortical stimulations)
macro-electrophysiological recordings
Time Frame: 12 months post-surgery compare to preoperative assessment (SEEG)
The relation between the presence in the epileptogenic zone of an activation in the other frequency bands (theta, alpha, beta) in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a post neuropsychological deficit
12 months post-surgery compare to preoperative assessment (SEEG)
micro-electrophysiological recordings
Time Frame: 12 months post-surgery compare to preoperative assessment (SEEG)
The relation between the presence in the epileptogenic zone of an activation in the other frequency bands (theta, alpha, beta) in at least 1 of the cognitive tasks performed during the ISD and the occurrence of a post neuropsychological deficit
12 months post-surgery compare to preoperative assessment (SEEG)

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Sylvain RHEIMS, MD, Hospices Civils de Lyon

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 23, 2017

Primary Completion (Estimated)

January 23, 2027

Study Completion (Estimated)

January 23, 2027

Study Registration Dates

First Submitted

March 9, 2017

First Submitted That Met QC Criteria

March 22, 2017

First Posted (Actual)

March 29, 2017

Study Record Updates

Last Update Posted (Estimated)

January 26, 2024

Last Update Submitted That Met QC Criteria

January 25, 2024

Last Verified

January 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Epilepsy

Clinical Trials on Dynamic Spectral Imaging (ISD)

3
Subscribe